NCT02220985 · OUTCOME

aGVHD Management - Secondary

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · Source last updated 2026-06-01

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to day 100

What was measured

Requirement for secondary systemic therapy for acute graft-versus-host disease (GVHD) management

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Requirement for secondary systemic therapy for acute graft-versus-host disease (GVHD) management
reporting Status: NOT_POSTED
time Frame: Up to day 100
title: aGVHD Management - Secondary
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice